health · HHS-NIH11

Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)

National Institutes of Health · PAR-27-007

Closed

Deadline

TBD

GRANTQUICK SUMMARYPlain-English Overview

Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required). National Institutes of Health. The National Institute of Neurological Disorders and Stroke (NINDS), in conjunction with additional Institutes/Centers (ICs)at the National Institutes of Health seek to support projects proposing Clinical Trials and Ancillary Studies that are conducted within NIH-Funded Clinical Trial Research... Funding amounts not specified.

Who Should Apply

Public And Indian Housing Authorities, Other eligible entities, Nonprofits (non-501c3), Other Native American Tribal Organizations, Independent school districts (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

•Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

The National Institute of Neurological Disorders and Stroke (NINDS), in conjunction with additional Institutes/Centers (ICs)at the National Institutes of Health seek to support projects proposing Clinical Trials and Ancillary Studies that are conducted within NIH-Funded Clinical Trial Research Networks.

The program will encourage applications for multi-center clinical trials to be conducted within an established Clinical Trial Research Network funded by one of multiple NIH Institutes and Centers. Following peer review, the IC will prioritize studies to be conducted within the established network infrastructure with cooperative oversight by the administering IC. The program will use the bi-phasic, milestone driven UG3/UH3 cooperative agreement activity code. Awards will initially support an up to 2- year milestone-driven planning and start-up phase, with possible transition to an implementation (UH3) phase of up to 5 additional years.

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. For additional information, potential applicants are encouraged to contact program staff listed below.

Who Can Apply

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Eligible Applicant Types

Public And Indian Housing AuthoritiesOther (see NOFO for details)Nonprofits without 501(c)(3)Other Tribal OrganizationsIndependent School DistrictsCounty GovernmentsCity/Township GovernmentsPrivate Colleges & UniversitiesFederally Recognized Tribal Governments501(c)(3) NonprofitsSmall BusinessesPublic Colleges & UniversitiesFor-Profit OrganizationsState GovernmentsSpecial District Governments

Funding Details

Cost Sharing Required?: No
Funding Instrument: other

Key Dates

Posted: March 16, 2026

Application Deadline: TBD (0 days remaining)

Agency Contact

NINDS Division of Clinical Research (DCR) Please contact via e-mail.

networkclinicaltrials@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov

View on Grants.gov